Provider grid Details of the Content Resources and services offered by appointed Providers under the NICE Electronic and Print Content Framework....
We’ve temporarily withdrawn this medtech innovation briefing to correct factual errors in the text.
Advice on improving the quality of economic models
Scholarships are one year opportunities to improve quality of care and contribute to your professional development
Everything NICE has said on respiratory conditions in an interactive flowchart
Everything NICE has said on managing generalised anxiety disorder in adults in primary, secondary and community care in an interactive flowchart
Everything NICE has said on preventing and managing pressure ulcers in all age groups in primary care and community settings in an interactive flowchart
NICE guidelines are evidence-based recommendations for health and care in England.
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Everything NICE has said on abortion care in an interactive flowchart.
NICE is unable to make a recommendation about the use in the NHS of ramucirumab (Cyramza) for treating unresectable hepatocellular carcinoma after sorafenib
1999 Creation of NICE The National Institute for Clinical Excellence became a legal entity in April. Our aim was to create consistent guidelines
Provider name: Blackwells Lot details Lot 2 - Electronic Books Lot 2 Agent - Print Books, Electronic Books Provider helpdesk
Chris Bird, Quality Standards Programme Manager, tells us how NICE developed the latest learning disability quality standards
NICE is unable to make a recommendation about the use in the NHS of ibrutinib (Imbruvica) with rituximab for treating Waldenstrom’s macroglobulinaemia in adults
Who can become a registered stakeholder? Registration is open to anyone with an interest in the topic who is one of the following: The company that
Evidence-based antimicrobial prescribing guidance for primary and secondary care with a focus on bacterial infection and antibiotic use.
Support for voluntary and community sector organisations using NICE guidance
Everything NICE has said on diagnosing and managing non-Hodgkin's lymphoma in adults and young people 16 years and older in an interactive flowchart
Find out more about being on a committee at NICE.
How a range of GPs can benefit from working with us on our committees to develop our guidance.
How NICE recommendations are being used to improve sexual health
A multi-disciplinary working group was set up to look at how the NICE guidance for dementia should be applied to adults with a learning disability.
Recommendation ID NG135/4 Question How effective and cost effective are education-based alcohol interventions targeted at children and young
Recommendation ID NG135/2 Question How effective and cost effective are individual, compared with group, education-based interventions for
Recommendation ID NG130/1 Question In a mild-to-moderate first presentation or inflammatory exacerbation of proctitis that is resistant
Recommendation ID NG130/2 Question What is the effectiveness of oral tacrolimus and systemic (intramuscular/subcutaneous/oral) methotrexate
Recommendation ID NG130/3 Question What is the clinical and cost effectiveness of prednisolone, budesonide, and beclometasone in addition
Recommendation ID CG30/1 Question Few women use contraception perfectly (that is, exactly in accordance with the product instructions) and
Recommendation ID NG135/3 Question How effective and cost effective are universal, education-based alcohol interventions for children and
Recommendation ID CG30/3 Question In addition to individual circumstances and needs, a woman's choice and acceptance of LARC may be influenced
Recommendation ID NG135/1 Question What components of alcohol education delivery contribute to its effectiveness for children and young
Recommendation ID NG131/1 Question What is the most suitable surveillance protocol (including the role of digital rectal examination [DRE]
Recommendation ID DG35/1 Question The committee recommended further research to determine if using the lead‑I electrocardiogram (ECG) devices
Recommendation ID NG129/1 Question What are the benefits, risk and cost effectiveness of enteral nutrition in maintaining remission in the
Recommendation ID DG35/2 Question The committee recommended that data should be collected to evaluate the system impact of adopting the
Recommendation ID NG131/7 Question In patients with negative MRI (Likert score 1 or 2), what is the next best diagnostic investigation to
Recommendation ID NG130/4 Question What is the clinical and cost effectiveness of prednisolone compared with aminosalicylates for the induction
Recommendation ID NG130/5 Question What is the clinical and cost effectiveness of prednisolone plus an aminosalicylate compared with beclometasone
Recommendation ID NG130/6 Question What are the benefits, risks and cost effectiveness of methotrexate, ciclosporin, tacrolimus, adalimumab